SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Library > White / Technical Paper

NXT LVL Clinical Trials. Direct-to-Patient: Your Top 10 Q&A.

Published: 12-Sep-2016 | Format: PDF file | Document type: White / Technical Paper
Related applications: Analytical (technologies & services)

Take your clinical trials to the next level. The direct-to-patient (DtP) model solves two of the largest issues plaguing clinical trials: patient recruitment and retention. This article answers the top 10 questions asked about DtP.

Download the Q&A to find answers to the following and more:

  • What are the major differences between DtP and traditional clinical trials?
  • How does a DtP model benefit patients?
  • How does a DtP model benefit trial sponsors?
  • What are the challenges and subsequent risks?

LATEST CONTENT FROM World Courier

World Courier shares its insights on successful importation of clinical trial drugs into China

Getting a clinical trial drug into China is a complex business. Any discrepancies in paperwork or the physical shipment can lead to delays at customs or China Inspection & Quarantine. World Courier shares its experience for successful shipping.

Discover what makes South Africa uniquely placed for running clinical trials in Africa

Down at the base of Africa is a country with amazing heritage, unique geography, and challenging patient populations. See why clinical trials happen in South Africa here

World Courier discusses how healthcare, supply chain and public safety are inextricably linked

In globalising the pharmaceutical industry oversight and control has increasingly become a challenge in managing product quality, consumer safety and organisational risk.

World Courier discusses strategies for ensuring a successful supply chain

Once deficiencies in the supply chain are identified, how can the pharmaceutical industry ensure it manages product quality, consumer safety and organizational risk?

Clinical trials: World Courier explores opportunities in Southeast Asia

Southeast Asia is a growing pharmaceutical market, with a population of 620 million. What opportunities are there for multinational companies to access this rich area?

Supplier's Info Centre

World Courier